![]() |
市場調查報告書
商品編碼
1661102
2025 年至 2033 年生物保存市場報告,按產品類型(生物保存設備、生物保存介質)、應用(治療應用、生物庫應用、藥物發現應用)和地區分類Biopreservation Market Report by Product Type (Biopreservation Equipment, Biopreservation Media), Application (Therapeutic Applications, Biobank Applications, Drug Discovery Applications), and Region 2025-2033 |
2024IMARC Group全球生物保存市場規模達到 85 億美元。大眾對個人化醫療的日益關注、對研發活動的投資不斷增加以及對罕見疾病的認知和理解不斷提高是推動市場發展的主要因素。
生物保存是指將生物材料(如細胞、組織、器官或整個生物體)在存活和功能狀態下長期保存的過程。該過程的目標是保持生物材料的完整性、活力和功能性,使其能夠儲存、運輸和用於各種目的,包括研究、臨床應用和工業過程。它在各個領域都有廣泛的應用,包括醫學、生物技術和用於儲存細胞、組織和器官以供移植、再生醫學和藥物開發的研究。
全球市場的主要驅動力是大眾對個人化醫療的日益關注。此外,政府、學術機構和私人組織在生命科學、生物技術和醫療保健領域的研發活動不斷增加的投資,為市場的發展提供了推動力。此外,隨著人們對罕見疾病和遺傳性疾病的認知和理解不斷提高,保存受影響人群的生物樣本的需求也日益增加。這些技術支援這些樣本的收集和儲存,以研究疾病機制、開發診斷方法並促進標靶治療的發展,從而滿足全球需求。此外,改進的冷凍保護劑、自動化系統和增強的儲存協議的發展正在擴大生物保存的能力和應用,因為它們有助於保持保存的生物材料的效率、可靠性和安全性,進一步創造了積極的市場前景。
生物銀行需求不斷成長
生物銀行需求的不斷成長對全球市場產生了重大影響。生物庫是儲存各種生物樣本(包括細胞、組織、血液、DNA 和其他生物材料)以用於研究和診斷目的的儲存庫。這些技術對於維護這些樣本的完整性、活力和功能性,確保其長期儲存和可用性發揮著至關重要的作用。大規模人群研究、臨床試驗和研究計畫需要多樣化且保存完好的生物樣本,而這些需求的日益成長正在影響全球生物庫領域。此外,人們對精準醫療和個人化醫療的日益關注也放大了生物庫的重要性,因為它們提供了可用於基因組測試、生物標記發現和客製化治療開發的全面樣本。
再生醫學的持續進步
再生醫學的進步對全球市場產生了重大影響。生物保存透過保存細胞、組織和工程結構的活力和功能,在再生醫學的成功中起著至關重要的作用,因為再生醫學的目的是利用基於細胞的療法、組織工程和其他創新方法來修復或替換受損的組織或器官。此外,這些技術對於在儲存和運輸過程中維持幹細胞的活力和效力至關重要。冷凍和玻璃化等冷凍保存方法通常用於保存幹細胞以供將來用於治療或研究。幹細胞保存規則和冷凍保護劑的進步提高了幹細胞的活力和解凍後功能,促進了市場的成長。
生物製藥產業的擴張
生物製藥產業的擴張是影響市場的重要因素。生物製藥產業專注於生物藥物的開發和生產,包括治療性蛋白質、抗體、疫苗和基於細胞的療法。生物保存對於確保這些複雜生物產品從開發到分銷的整個生命週期的穩定性、品質和完整性起著至關重要的作用。由於生物藥物對溫度、光照和濕度等環境條件高度敏感,因此對這些技術的需求大幅增加,因為它們對於在儲存和運輸過程中保持這些藥物的穩定性和品質至關重要。透過採用冷凍保存、冷凍乾燥或其他適當的保存方法,生物製藥公司可以延長其產品的保存期限,並確保其給患者使用時的有效性和安全性。
The global biopreservation market size reached USD 8.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 20.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.98% during 2025-2033. The growing focus on personalized medicine among the masses, the increasing investments in research and development (R&D) activities and the rising awareness and understanding of rare diseases are some of the major factors propelling the market.
Biopreservation refers to the process of preserving biological materials, such as cells, tissues, organs, or whole organisms, in a viable and functional state for extended periods. The goal of the process is to maintain the integrity, viability, and functionality of the biological material, allowing it to be stored, transported, and used for various purposes, including research, clinical applications, and industrial processes. It has numerous applications across various fields, including medicine, biotechnology, and research for enabling the storage of cells, tissues, and organs for transplantation, regenerative medicine, and drug development.
The global market is primarily driven by the growing focus on personalized medicine among the masses. Moreover, the increasing investments in research and development (R&D) activities by governments, academic institutions, and private organizations in the fields of life sciences, biotechnology, and healthcare is providing a boost to the market. Furthermore, the rising awareness and understanding of rare diseases and genetic disorders among individuals led to an increasing need to preserve biological samples from affected masses. These techniques support the collection and storage of these samples for studying disease mechanisms, developing diagnostics, and facilitating the development of targeted therapies, thereby contributing to the demand on the global level. Additionally, the development of improved cryoprotectants, automated systems, and enhanced storage protocols, are expanding the capabilities and applications of biopreservation as they help in maintaining the efficiency, reliability, and safety of preserved biological materials, further creating a positive market outlook.
Increasing Demand for Biobanking
The increasing demand for biobanking has a significant impact on the global market. Biobanks are repositories that store various biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research and diagnostic purposes. These techniques play a crucial role in maintaining the integrity, viability, and functionality of these samples, ensuring their long-term storage and usability. The growing need for large-scale population-based studies, clinical trials, and research projects that require access to diverse and well-preserved biological samples is influencing the overall biobanks segment across the globe. Additionally, the increasing focus on precision medicine and personalized healthcare has amplified the importance of biobanks as they provide a comprehensive collection of samples that can be used for genomic testing, biomarker discovery, and the development of tailored treatments.
Continual Advancements in Regenerative Medicine
Advancements in regenerative medicine have a significant influence on the global market. Biopreservation plays a crucial role in the success of regenerative medicine by preserving the viability and functionality of cells, tissues, and engineered constructs since regenerative medicine aims to restore or replace damaged tissues or organs using cell-based therapies, tissue engineering, and other innovative approaches. Moreover, these techniques are essential for maintaining the viability and potency of stem cells during storage and transportation. Cryopreservation methods, such as freezing and vitrification, are commonly employed to preserve stem cells for future use in therapies or research. Advancements in stem cell preservation protocols and cryoprotectants have enhanced the viability and post-thaw functionality of stem cells, contributing to the growth of the market.
The Expansion of the Biopharmaceutical Industry
The expansion of the biopharmaceutical industry is a significant factor influencing the market. The biopharmaceutical industry focuses on the development and production of biological drugs, including therapeutic proteins, antibodies, vaccines, and cell-based therapies. Biopreservation plays a vital role in ensuring the stability, quality, and integrity of these complex biological products throughout their lifecycle, from development to distribution. Since biological drugs are highly sensitive to environmental conditions, such as temperature, light, and moisture, there has been a considerable increase in the demand for these techniques as they are essential for maintaining the stability and quality of these drugs during storage and transportation. By employing cryopreservation, lyophilization, or other appropriate preservation methods, biopharmaceutical companies can extend the shelf life of their products and ensure their efficacy and safety when administered to patients.
Biopreservation equipment dominates the market
Biopreservation equipment plays a dominant role in the market due to its essential role in preserving and storing biological materials. It refers to the specialized devices, instruments, and infrastructure used in various preservation techniques, such as cryopreservation, vitrification, lyophilization, and chemical fixation. This equipment ensures the optimal conditions for preserving the viability, integrity, and functionality of biological samples over extended periods. Additionally, biopreservation equipment manufacturers adhere to strict quality standards and regulations to ensure the reliability and safety of their products. The increasing demand for biobanking and research activities on account of advancements in genomics, personalized medicine, and drug development, is fueling the demand for these equipment.
On the other hand, biopreservation media, also known as cryopreservation media or storage media, are specifically designed to provide the optimal environment for preserving cells, tissues, and other biological samples. These media contain various components, including cryoprotectants, osmotic agents, antioxidants, and nutrients, which help protect cells from freezing or storage-related damage and support their viability and functionality upon thawing or reconstitution.
Biobank applications hold the largest share in the market
Biobanks are specialized facilities that are widely constructed to store and manage large collections of biological samples, including cells, tissues, blood, DNA, and other biomaterials, for research, clinical, or diagnostic purposes. Biobank applications heavily rely on biopreservation techniques in order to ensure the long-term preservation and usability of the stored samples. Biobank facilities often participate in collaborative research initiatives and multi-center studies. These initiatives involve sharing and exchanging samples among different biobanks to facilitate large-scale research projects. Biobanks involved in collaborative research efforts rely on effective techniques to ensure the compatibility, integrity, and viability of the samples during transportation and exchange.
On the contrary, drug discovery applications also play a significant role in positively affecting the market and driving the demand for these technologies and solutions. As drug discovery relies heavily on the use of cell lines and primary cells for screening, testing, and studying the efficacy and safety of potential drug candidates. Also, these technologies and equipment are essential for storing and maintaining the viability of cell-based assays and tissue samples used in high-throughput screening (HTS). The ability to preserve and retrieve these samples accurately and efficiently is crucial for conducting large-scale screening campaigns is accelerating the drug discovery process.
North America exhibits a clear dominance, accounting for the largest market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Latin America and the Middle East and Africa.
North America held the biggest market share due to the presence of well-established healthcare infrastructure, including advanced medical research institutions, pharmaceutical companies, and biotechnology firms. These organizations drive significant demand for these technologies to support their research, drug discovery, and clinical applications.
Moreover, North America has a robust network of biobanks, including government-funded initiatives, academic biorepositories, and private biobanks. These biobanks collect and store a wide range of biological samples for research and clinical applications, making them a significant consumer of these technologies. The well-developed infrastructure and standardization practices in North American biobanks contribute to the region's dominance in the market.
On the other hand, Asia Pacific is another largest region in this domain due to its large population and healthcare needs and the rapidly expanding biopharmaceutical industry. Furthermore, the concept of personalized medicine, tailoring medical treatments to individual patients based on their genetic and biological characteristics, is also gaining traction in the Asia Pacific region.
Top companies operating in the market recognize the growing demand for biobanking services. Biobanks serve as repositories for various biological samples used in research, diagnostics, and personalized medicine. The need for long-term preservation and storage of these samples drives the demand for biopreservation technologies and solutions. Moreover, numerous leading players are acknowledging the significant advancements in regenerative medicine and cell-based therapies. These therapies rely on the preservation of cells, tissues, and engineered constructs to ensure their viability and functionality. The growth in regenerative medicine and cell therapy drives the development and adoption of advanced these technologies and protocols. Furthermore, several key players operating in the market recognize the expanding biopharmaceutical industry. This is encouraging them to heavily invest in ensuring the quality and integrity of these samples, which is creating a positive market outlook.